Annual Meeting 2003
Back to the Future – Upgrading classical test strategies for innovative drugs
February 23 – 25, 2003, Bonn, Germany
Workshops and sessions during the pre-symposium day concentrated on medical and report writing, the FDA guidelines referring to time-series data, the Declaration of Helsinki and the European directives regulating the conduct of clinical trials. Symposium and Poster sessions focussed on current regulatory and socio-economical aspects of drug development and their perspectives, the evolution of clinical trial methods, especially in the development of anti-cancer, anti-inflammatory, anti-neurodegenerative and genetically engineered drugs.
